A variety of human diseases including neuronal degeneration, diabetes, cardiac hypertrophy, vascular disorders, and cancer are associated with dysregulation of AKT signaling, and thus a great effort has been directed toward development of ATK inhibitors [77, 78]. This evidence concerns the gene AKT1 and vascular disorder.